August 2013

Knowledge Is PowerA Case for Wider Herpes Simplex Virus Serologic Testing

Author Affiliations
  • 1Departments of Medicine, Laboratory Medicine, and Epidemiology, University of Washington, and Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle

Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Pediatr. 2013;167(8):689-690. doi:10.1001/jamapediatrics.2013.459

A recent headline in the Los Angeles Times proclaimed “US Panel Advises HIV Tests for Everyone Ages 15 to 64.”1 A few months prior, the Centers for Disease Control and Prevention recommended that the generation born between 1945 and 1965 be tested for hepatitis C infection at least once. In contrast, testing for herpes simplex virus type 2 (HSV-2) infection is not only not recommended but actively discouraged.2 Why is there such a difference in the public health view of the importance of testing and treatment of human immunodeficiency virus (HIV) and hepatitis C vs HSV?

First Page Preview View Large
First page PDF preview
First page PDF preview